Current Assets
AFS and Trading Securities - Unrealized Loss Position Fair Value
CVS Health AFS and Trading Securities - Unrealized Loss Position Fair Value increased by 102.5% to $12.82B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.5%, from $9.90B to $12.82B. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position Fair Value shows an upward trend with a 47.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2018
Last reportedQ1 2026May 6, 2026
Metric ID:
afs_trading_securities_unrealized_loss_fvHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.07B | $4.39B | $7.38B | $13.55B | $16.92B | $19.46B | $18.49B | $16.95B | $17.66B | $18.18B | $12.55B | $14.24B | $15.00B | $7.46B | $13.24B | $9.90B | $6.65B | $5.44B | $6.33B | $12.82B |
| QoQ Change | — | +43.1% | +68.2% | +83.5% | +24.9% | +15.0% | -5.0% | -8.4% | +4.2% | +2.9% | -31.0% | +13.5% | +5.3% | -50.3% | +77.6% | -25.2% | -32.9% | -18.2% | +16.4% | +102.5% |
| YoY Change | — | — | — | — | +451.6% | +343.2% | +150.4% | +25.1% | +4.4% | -6.6% | -32.1% | -16.0% | -15.0% | -59.0% | +5.5% | -30.5% | -55.7% | -27.0% | -52.2% | +29.5% |
Range$3.07B – $19.46B
CAGR+35.1%
Avg YoY Growth+44.7%
Median YoY Growth-10.8%
Current Streak2 quarters growth
AFS and Trading Securities - Unrealized Loss Position Fair Value at Other Companies
Frequently Asked Questions
- What is CVS Health's afs and trading securities - unrealized loss position fair value?
- CVS Health (CVS) reported afs and trading securities - unrealized loss position fair value of $12.82B in Q1 2026.
- How has CVS Health's afs and trading securities - unrealized loss position fair value changed year-over-year?
- CVS Health's afs and trading securities - unrealized loss position fair value increased by 29.5% year-over-year, from $9.90B to $12.82B.
- What is the long-term trend for CVS Health's afs and trading securities - unrealized loss position fair value?
- Over 5 years (2020 to 2025), CVS Health's afs and trading securities - unrealized loss position fair value has grown at a 47.2% compound annual growth rate (CAGR), from $915.00M to $6.33B.